Insider Transactions in Q2 2023 at Staar Surgical CO (STAA)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2023
|
Stephen C Farrell |
BUY
Exercise of conversion of derivative security
|
Direct |
1,709
+17.12%
|
-
|
|
Jun 15
2023
|
Thomas G Frinzi President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
501
-0.54%
|
$26,052
$52.67 P/Share
|
|
Jun 15
2023
|
K Peony Yu Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,709
+38.02%
|
-
|
|
Jun 15
2023
|
Aimee S Weisner |
BUY
Exercise of conversion of derivative security
|
Direct |
3,417
+50.0%
|
-
|
|
Jun 15
2023
|
Gilbert H Kliman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,417
+26.14%
|
-
|
|
Jun 06
2023
|
Patrick F. Williams Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,987
-4.19%
|
$107,298
$54.79 P/Share
|
|
Jun 06
2023
|
Patrick F. Williams Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,121
+9.75%
|
-
|
|
May 08
2023
|
Warren Foust Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,331
+50.0%
|
-
|
|
May 08
2023
|
Magda Michna Chief Clinical, Regulatory, |
BUY
Exercise of conversion of derivative security
|
Direct |
14,047
+50.0%
|
-
|